ID   PA2GD_HUMAN             Reviewed;         145 AA.
AC   Q9UNK4; A8K2Z1; B1AEL9; Q9UK01;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-FEB-2002, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Group IID secretory phospholipase A2;
DE            Short=GIID sPLA2;
DE            Short=sPLA2-IID;
DE            EC=3.1.1.4;
DE   AltName: Full=PLA2IID;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 2D;
DE   AltName: Full=Secretory-type PLA, stroma-associated homolog;
DE   Flags: Precursor;
GN   Name=PLA2G2D; Synonyms=SPLASH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLY-80, AND CHARACTERIZATION.
RX   PubMed=10455175; DOI=10.1074/jbc.274.35.24973;
RA   Ishizaki J., Suzuki N., Higashino K., Yokota Y., Ono T., Kawamoto K.,
RA   Fujii N., Arita H., Hanasaki K.;
RT   "Cloning and characterization of novel mouse and human secretory
RT   phospholipase A2s.";
RL   J. Biol. Chem. 274:24973-24979(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11196711; DOI=10.1038/sj.gene.6363659;
RA   Shakhov A.N., Rubtsov A.V., Lyakhov I.G., Tumanov A.V.,
RA   Nedospasov S.A.;
RT   "SPLASH (PLA(2)IID), a novel member of phospholipase A2 family, is
RT   associated with lymphotoxin-deficiency.";
RL   Genes Immun. 1:191-199(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-80.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-65; ARG-73;
RP   GLY-80; ARG-96; CYS-121 AND LEU-121.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2-
CC       linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed
CC       than the other phospholipids examined.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10035, ECO:0000255|PROSITE-ProRule:PRU10036}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Binds 1 Ca(2+) ion per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimally active at neutral to alkaline pHs with 2 mM Ca(2+).;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Broadly expressed.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pla2g2d/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF112982; AAD51390.1; -; mRNA.
DR   EMBL; AF188625; AAF09020.1; -; mRNA.
DR   EMBL; AK290406; BAF83095.1; -; mRNA.
DR   EMBL; EU447440; ACA06110.1; -; Genomic_DNA.
DR   EMBL; AL158172; CAC13159.1; -; Genomic_DNA.
DR   EMBL; BC025706; AAH25706.1; -; mRNA.
DR   CCDS; CCDS203.1; -.
DR   RefSeq; NP_001258743.1; NM_001271814.1.
DR   RefSeq; NP_036532.1; NM_012400.3.
DR   UniGene; Hs.189507; -.
DR   ProteinModelPortal; Q9UNK4; -.
DR   SMR; Q9UNK4; -.
DR   BioGrid; 117662; 1.
DR   STRING; 9606.ENSP00000364246; -.
DR   BindingDB; Q9UNK4; -.
DR   ChEMBL; CHEMBL4281; -.
DR   DrugBank; DB03017; Lauric Acid.
DR   DrugBank; DB03193; Stearic acid.
DR   GuidetoPHARMACOLOGY; 1418; -.
DR   SwissLipids; SLP:000000652; -.
DR   iPTMnet; Q9UNK4; -.
DR   PhosphoSitePlus; Q9UNK4; -.
DR   DMDM; 20139286; -.
DR   PaxDb; Q9UNK4; -.
DR   PeptideAtlas; Q9UNK4; -.
DR   PRIDE; Q9UNK4; -.
DR   DNASU; 26279; -.
DR   Ensembl; ENST00000375105; ENSP00000364246; ENSG00000117215.
DR   GeneID; 26279; -.
DR   KEGG; hsa:26279; -.
DR   UCSC; uc001bcz.5; human.
DR   CTD; 26279; -.
DR   DisGeNET; 26279; -.
DR   GeneCards; PLA2G2D; -.
DR   HGNC; HGNC:9033; PLA2G2D.
DR   MIM; 605630; gene.
DR   neXtProt; NX_Q9UNK4; -.
DR   OpenTargets; ENSG00000117215; -.
DR   PharmGKB; PA33363; -.
DR   eggNOG; KOG4087; Eukaryota.
DR   eggNOG; ENOG411283D; LUCA.
DR   GeneTree; ENSGT00760000119160; -.
DR   HOGENOM; HOG000231749; -.
DR   HOVERGEN; HBG008137; -.
DR   InParanoid; Q9UNK4; -.
DR   KO; K01047; -.
DR   OMA; CACDKEV; -.
DR   OrthoDB; EOG091G0UZ3; -.
DR   PhylomeDB; Q9UNK4; -.
DR   TreeFam; TF319283; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   ChiTaRS; PLA2G2D; human.
DR   GeneWiki; PLA2G2D; -.
DR   GenomeRNAi; 26279; -.
DR   PRO; PR:Q9UNK4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117215; -.
DR   CleanEx; HS_PLA2G2D; -.
DR   ExpressionAtlas; Q9UNK4; baseline and differential.
DR   Genevisible; Q9UNK4; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0002361; P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:ProtInc.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    145       Group IID secretory phospholipase A2.
FT                                /FTId=PRO_0000022755.
FT   ACT_SITE     67     67       {ECO:0000250}.
FT   ACT_SITE    112    112       {ECO:0000250}.
FT   METAL        47     47       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        49     49       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        51     51       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        68     68       Calcium. {ECO:0000250}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     46    138       {ECO:0000250}.
FT   DISULFID     48     64       {ECO:0000250}.
FT   DISULFID     63    118       {ECO:0000250}.
FT   DISULFID     69    145       {ECO:0000250}.
FT   DISULFID     70    111       {ECO:0000250}.
FT   DISULFID     79    104       {ECO:0000250}.
FT   DISULFID     97    109       {ECO:0000250}.
FT   VARIANT      65     65       Q -> H (in dbSNP:rs62541890).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055387.
FT   VARIANT      73     73       H -> R (in dbSNP:rs62541891).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055388.
FT   VARIANT      80     80       S -> G (in dbSNP:rs584367).
FT                                {ECO:0000269|PubMed:10455175,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_012741.
FT   VARIANT      96     96       H -> R (in dbSNP:rs62541892).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055389.
FT   VARIANT     121    121       R -> C (in dbSNP:rs62541900).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055390.
FT   VARIANT     121    121       R -> L (in dbSNP:rs62541901).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055391.
SQ   SEQUENCE   145 AA;  16546 MW;  CF3A49DE516BD1EF CRC64;
     MELALLCGLV VMAGVIPIQG GILNLNKMVK QVTGKMPILS YWPYGCHCGL GGRGQPKDAT
     DWCCQTHDCC YDHLKTQGCS IYKDYYRYNF SQGNIHCSDK GSWCEQQLCA CDKEVAFCLK
     RNLDTYQKRL RFYWRPHCRG QTPGC
//
